ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 66 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,069,000 | -24.2% | 249,215 | -46.4% | 0.05% | -31.1% |
| Q2 2021 | $1,410,000 | -17.4% | 465,317 | -16.4% | 0.07% | -36.2% |
| Q1 2021 | $1,707,000 | +3.3% | 556,617 | +19.6% | 0.12% | -21.6% |
| Q4 2020 | $1,652,000 | +6.9% | 465,317 | -11.0% | 0.15% | -41.0% |
| Q3 2020 | $1,545,000 | -80.4% | 522,649 | -87.9% | 0.25% | -80.8% |
| Q2 2020 | $7,882,000 | +80.2% | 4,331,020 | 0.0% | 1.31% | +30.5% |
| Q1 2020 | $4,374,000 | +69.9% | 4,331,020 | +367.6% | 1.00% | +348.2% |
| Q4 2019 | $2,575,000 | – | 926,200 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
| QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
| Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
| Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
| Kepos Capital LP | 200,000 | $778,000 | 0.06% |
| XTX Topco Ltd | 29,026 | $113,000 | 0.06% |